Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

A Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.

Studieöversikt

Detaljerad beskrivning

This is a retrospective study to determine if there is a relationship between intravenous infusion of ketamine given for analgesia and the use of additional opioid pain medications and patient reported pain levels before and during ketamine usage. The investigator anticipates that records of up to 700 subjects will be reviewed for eligibility. The time period 24 hours before the initial ketamine therapy is initiated along with 24 & 48 hours after the start of ketamine therapy will be the time periods examined. The average/minimum/maximum pain scores during these time periods will be used. Medication usage will be calculated over the 24 hour time periods.

This protocol is presented as an initial step in exploring the possible relationship between the administration of ketamine as an analgesic agent, the potential reduction in pain medications, and the potential reduction of pain levels. With this the goals/objectives are as follows:

Objectives

  1. To compare morphine consumption in battlefield injured patients with acute pain 24 hours before the initiation of a ketamine infusion to the subsequent 48 hours following the start of infusion.
  2. To compare average/minimum/maximum pain scores in battlefield injured patients with acute pain 24 hours before the initiation of a ketamine infusion to the subsequent 48 hours following the start of infusion.
  3. To describe the pain trajectory in battlefield injured patients with acute pain after the initiation of ketamine infusions.
  4. To measure the absolute and proportional incidence of ketamine associated side effects in battlefield injured patients with acute pain following the initiation of ketamine infusions.

Studietyp

Observationell

Inskrivning (Faktisk)

80

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Maryland
      • Bethesda, Maryland, Förenta staterna, 20889
        • Walter Reed National Military Medical Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

Male and female military health care beneficiaries age 18 years and older

Beskrivning

Inclusion Criteria:

  • Battlefield injured from January 2007 to December 2013
  • Prescribed a ketamine infusion for acute pain
  • Awake, alert (non intubated/sedated), and able to report pain scores 24 hours prior to the start of infusion and up to 48 hours following infusion

Exclusion Criteria:

  • Patients who did not receive an injury in theater and did not receive ketamine while being treated by the APS or WRNMMC/WRAMC hospital staff
  • No continuous perineural catheter or epidural placement while on ketamine infusion
  • Less than 18 years old

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Battlefield Injury with ketamine treatment
Patients who received ketamine infusions to treat pain from January 2007 to December 2013.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Opioid consumption measured in morphine equivalents
Tidsram: 24 hours before ketamine infusion
Amount of opioids consumed within time frame
24 hours before ketamine infusion
Opioid consumption measured in morphine equivalents
Tidsram: 24 hours after ketamine infusion
Amount of opioids consumed within time frame
24 hours after ketamine infusion
Opioid consumption measured in morphine equivalents
Tidsram: 48 hours after ketamine infusion
Amount of opioids consumed within time frame
48 hours after ketamine infusion
Pain scores
Tidsram: 24 hours before ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10

24 hours before ketamine infusion
Pain scores
Tidsram: 24 hours after ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10

24 hours after ketamine infusion
Pain scores
Tidsram: 48 hours after ketamine infusion

Defense and Veterans Pain Rating Scale Pain scores recorded based on the Defense and Veterans Pain Rating Scale

Rate the severity of your CURRENT pain:

0 - No Pain

  1. - Hardly notice pain
  2. - Notice pain, does not interfere with activities
  3. - Sometimes distracts me
  4. - Distracts me, can do usual activities
  5. - Interrupts some activities
  6. - Hard to ignore, avoid usual activities
  7. - Focus of attention, prevents doing daily activities
  8. - Awful, hard to do anything
  9. - Can't bear pain, unable to do anything
  10. - As bad as it could be, nothing else matters

Circle the number that describes how, during the past 24 hours, pain has interfered with your usual activity:

0 - 10 (0=does not interfere, 10=completely interferes)

Circle the number that describes how, during the past 24 hours, pain has interfered with sleep:

0 - 10 (0=does not interfere, 10=completely interferes) Circle the number that describes how, during the past 24 hours, pain has affected your mood: 0-10

48 hours after ketamine infusion
Number of ketamine side effects
Tidsram: 24 hours before ketamine infusion
Recorded side effects after ketamine infusion
24 hours before ketamine infusion
Number of ketamine side effects
Tidsram: 24 after ketamine infusion
Recorded side effects after ketamine infusion
24 after ketamine infusion
Number of ketamine side effects
Tidsram: 48 hours after ketamine infusion
Recorded side effects after ketamine infusion
48 hours after ketamine infusion

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Michael Kent, MD, Walter Reed National Military Medical Center

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 augusti 2014

Primärt slutförande (Faktisk)

1 augusti 2017

Avslutad studie (Faktisk)

30 augusti 2017

Studieregistreringsdatum

Först inskickad

12 augusti 2019

Först inskickad som uppfyllde QC-kriterierna

13 augusti 2019

Första postat (Faktisk)

15 augusti 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

15 augusti 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

13 augusti 2019

Senast verifierad

1 augusti 2019

Mer information

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Analgesi

Kliniska prövningar på ketamin

3
Prenumerera